Insights Into the Function and Clinical Application of HDAC5 in Cancer Management

Area of Science:

• Molecular Biology
• Oncology
• Epigenetics

Background:

• Histone deacetylase 5 (HDAC5) is a class II histone deacetylase.
• Aberrant HDAC5 expression is linked to various cancer types.
• HDAC5 plays roles in cell proliferation, invasion, immune response, and stemness maintenance.

Purpose of the Study:

• To provide a comprehensive overview of HDAC5 in cancer.
• To discuss the expression, biological functions, and regulatory mechanisms of HDAC5.
• To highlight the clinical significance of HDAC5 as a therapeutic target.

Main Methods:

• Literature review of existing studies on HDAC5.
• Analysis of HDAC5 expression patterns in different cancers.
• Synthesis of data on HDAC5's biological functions and regulatory pathways.

Main Results:

• HDAC5 is frequently overexpressed in numerous cancers.
• HDAC5 influences key cancer hallmarks including proliferation, invasion, and immune evasion.
• Epigenetic reprogramming is a critical factor in tumorigenesis involving HDAC5.

Conclusions:

• HDAC5 is a validated therapeutic target for anticancer drug development.
• Understanding HDAC5's multifaceted roles is crucial for effective cancer therapy.
• Targeting HDAC5 offers a promising strategy for epigenetic-based cancer treatments.